Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (Q42917584)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 9, 2010

Language	Label	Description	Also known as
English	Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial	scientific article published on October 9, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute coronary syndrome

1 reference

based on heuristic

inferred from title

coronary balloon angioplasty

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817281

6 July 2024

Philippe Gabriel Steg

12

object named as

Philippe Gabriel Steg

0 references

John W. Eikelboom

object named as

John W Eikelboom

3

0 references

Gilles Montalescot

14

object named as

Gilles Montalescot

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Christopher B. Granger

6

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

23

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Susan Chrolavicius

20

object named as

Susan Chrolavicius

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jean-Pierre Bassand

13

object named as

Jean-Pierre Bassand

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

11

object named as

Petr Widimsky

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

10

object named as

Alvaro Avezum

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

9

object named as

Andrzej Budaj

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Harvey D. White

19

object named as

Harvey D White

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

4

object named as

Sanjit S Jolly

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1

object named as

Shamir R Mehta

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Hans-Jürgen Rupprecht

8

object named as

Hans-Jurgen Rupprecht

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Campbell D Joyner

5

object named as

Campbell D Joyner

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

22

object named as

Keith A A Fox

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

7

object named as

David P Faxon

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

21

object named as

Peggy Gao

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jean-Francois Tanguay

2

object named as

Jean-Francois Tanguay

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Carlos Macaya

15

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Giuseppe Di Pasquale

16

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Kari Niemela

17

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

CURRENT-OASIS 7 trial investigators

24

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Shamir R. Mehta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817281

6 July 2024

Petr Widimsky

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817281

6 July 2024

Andrew E. Ajani

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817281

6 July 2024

Keith A. A. Fox

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817281

6 July 2024

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

9 October 2010

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817281

6 July 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0140673610610884?httpAccept=text/xml

1 reference

10.1016/S0140-6736(10)61088-4

https://api.crossref.org/works/10.1016/S0140-6736(10)61088-4

6 July 2024

https://api.elsevier.com/content/article/PII:S0140673610610884?httpAccept=text/plain

1 reference

10.1016/S0140-6736(10)61088-4

https://api.crossref.org/works/10.1016/S0140-6736(10)61088-4

6 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

376

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

9748

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1233-1243

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angiop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961088-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61088-4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42917584&oldid=2197188639"